0001290929-23-000006.txt : 20230123
0001290929-23-000006.hdr.sgml : 20230123
20230123131512
ACCESSION NUMBER: 0001290929-23-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230123
FILED AS OF DATE: 20230123
DATE AS OF CHANGE: 20230123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wolf James G.
CENTRAL INDEX KEY: 0001419248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09974
FILM NUMBER: 23543379
MAIL ADDRESS:
STREET 1: 105, FLYWAY DRIVE
CITY: KIAWAH ISLAND
STATE: SC
ZIP: 29455
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZO BIOCHEM INC
CENTRAL INDEX KEY: 0000316253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 132866202
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
BUSINESS PHONE: 5167555500
MAIL ADDRESS:
STREET 1: ENZO BIOCHEM INC
STREET 2: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2023-01-23
0
0000316253
ENZO BIOCHEM INC
ENZ
0001419248
Wolf James G.
105, FLYWAY DRIVE
KIAWAH ISLAND
SC
29455
0
0
1
0
Common Stock, $0.01 par value
2023-01-23
4
C
0
228700
2.5
A
4043700
D
Common Stock, $0.01 par value
2023-01-23
4
C
0
34500
5
A
4078200
D
Common Stock, $0.01 par value
418500
I
See Footnote
Short Put Option (obligation to buy)
2.5
2023-01-23
4
C
0
2287
0
D
2022-11-01
2023-01-20
Common Stock, $0.01 par value
228700
0
D
Short Put Option (obligation to buy)
5
2023-01-23
4
C
0
345
0
D
2022-10-28
2023-01-20
Common Stock, $0.01 par value
34500
0
D
The counterparty to certain of the Reporting Person's outstanding short put options exercised such options and the Reporting Person was obligated to purchase these shares at an exercise price of $2.50 per share.
The counterparty to certain of the Reporting Person's outstanding short put options exercised such options and the Reporting Person was obligated to purchase these shares at an exercise price of $5.00 per share.
These 418,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse, 110,000 shares owned directly by the Reporting Person's sibling and 170,500 shares owned directly by adult children of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any.
James G. Wolf
2023-01-23